RAC PHARMACEUTICALS EXAM 2024-2025 /COMPLETE ACTUAL EXAM QUESTIONS AND CORRECT ANSWERS (VERIFIED ANSWERS) ALREADY GRADED A+. When would you have a type A meeting? - ANSWER-dispute resolution, Clinical Holds, Special Protocol Assignment, Post Action Meeting (held within 30 days, with FDA response in 14 to schedule, briefing materials are need at least two weeks before the meeting) When would you have a type B meeting? - ANSWER-preIND, EOP1, EOP2, PreNDA, REMS/PMRs (FDA scheduling confirmation within 21 days, meeting within 60 days, briefing materials needed 1 month before); When would you have a type C meeting? - ANSWER-All other development meetings (can also be granted as writing response only; FDA scheduling within 21 days, meeting within 75 days and briefing materials needed 1 month before) When would you schedule a Pre-IND meeting? - ANSWER-When you have a life threating or dibilitating disease to required animal studies needed to initate human trials- (discuss and reach an agreement) When would you schedule a EOP1 meeting? - ANSWER-When you have an accelerated approval drug to agree on phase 2 trials before startingA sponsor's drug development program has come to a standstill and is need of a meeting with FDA. The company decides to schedule